MSACW (Medicus Sciences Acquisition) Long-Term Debt: $0.00 Mil (As of Sep. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MSACW Medicus Sciences Acquisition Corp MSACW
24 GF Score
Price $0.00
! 1 Warning Sign
View Full Analysis

What is Medicus Sciences Acquisition Long-Term Debt?

Medicus Sciences Acquisition MSACW 24 Long-Term Debt is $0.00 Mil as of Sep. 2022. GuruFocus rates MSACW with a GF Score™ of 24/100. The stock has 1 warning sign investors should review.

Medicus Sciences Acquisition's Long-Term Debt for the quarter that ended in Sep. 2022 was $0.00 Mil.

Medicus Sciences Acquisition  (NAS:MSACW) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Medicus Sciences Acquisition Long-Term Debt Related Terms

Medicus Sciences Acquisition Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Medicus Sciences Acquisition's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicus Sciences Acquisition Long-Term Debt Chart

Medicus Sciences Acquisition Annual Data
Trend Dec20 Dec21
Long-Term Debt
0.00 0.00

Medicus Sciences Acquisition Quarterly Data
Nov20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Long-Term Debt Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
MSACW
24GF Score
Medicus Sciences Acquisition Corp MSACW
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.00 Mil mean?
Medicus Sciences Acquisition (MSACW) has a Long-Term Debt of $0.00 Mil as of Sep. 2022.
Is Medicus Sciences Acquisition's Long-Term Debt too high?
Medicus Sciences Acquisition's current Long-Term Debt is $0.00 Mil. Overall, Medicus Sciences Acquisition has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Medicus Sciences Acquisition's Long-Term Debt compare to GENQ and DUET?
Medicus Sciences Acquisition's Long-Term Debt of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Diversified Financial Services company?
A good Long-Term Debt depends on the Diversified Financial Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Medicus Sciences Acquisition's current Long-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicus Sciences Acquisition stock overvalued right now?
Medicus Sciences Acquisition (MSACW) has a current Long-Term Debt of $0.00 Mil. The current Long-Term Debt is $0.00 Mil. Medicus Sciences Acquisition's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Medicus Sciences Acquisition (MSACW), the current Long-Term Debt is $0.00 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicus Sciences Acquisition Business Description

Address 152 West 57th Street, Floor 20, New York, NY, USA, 10019
Medicus Sciences Acquisition Corp is a blank check company.
24GF Score

Get the complete analysis for MSACW

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price